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ABSTRACT 
The hepatoprotective activity of the aqueous extracts of S. venulosa (AESV) and S. wallichiana 
(AESW) leaves on carbon tetrachloride (CCl4)-induced liver damage in albino rats was 
investigated. Animals were pretreated with the AESV (250 and 500 mg/kg body weight) and 
AESW (250 and 500 mg/kg body weight) for 15 days and then challenged with CCl4 (1 ml/kg 
body weight) in olive oil (1:1 v/v) on the 15th day. The degree of protection was measured by 
using biochemical parameters such as serum glutamate oxalate transaminase (SGOT), serum 
glutamate pyruvate transaminase (SGPT), alkaline phosphatase (ALP), total protein and total 
bilirubin. Further the effects of both the extracts on catalase (CAT), peroxidase (Px) and 
superoxide dismutase (SOD) were estimated in both CCl4 treated and extract treated groups. Oral 
administration of AESV and AESW (500 mg/kg body weight) significantly protected from CCl4-
induced elevation in SGOT, SGPT, ALP, total bilirubin, total protein and decrease in the activities 
of hepatic antioxidant enzymes namely SOD, CAT and Px. The extracts (AESV and AESW at 500 
mg/kg body weight) also protected against histopathological damage induced by CCl4 such as 
distorted hepatocytes and necrosis. The present study suggests that AESV has potent antioxidant 
and hepatoprotective activity when compared to AESW. 
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INTRODUCTION 
The liver is the second largest glandular organ of the body and plays a vital role in metabolizing 
the carbohydrate, lipids, proteins and detoxifying xenobiotics and drugs
1
. The blood flow to the 
liver is around 20 to 25% of the total cardiac output. About 20,000 deaths are found every year due 
to liver disorders
2
. Liver diseases represent a major health burden worldwide, with liver cirrhosis 
being the ninth leading cause of death in western countries
3
. Therefore, treating the liver diseases 
with plant derived products which are accessible and do not require laborious pharmaceutical 
synthesis seems highly attractive. Exposure to various organic compounds, including a number of 
environmental pollutants and drugs can cause cellular damages through metabolic activation of 
those compounds to highly reactive substances such as reactive oxygen species (ROS). Thus, the 
identification of antioxidants, which can retard the process of lipid peroxidation by blocking the 
generation of free radical chain reaction, has gained importance in recent years. In living systems, 
varieties of antioxidant mechanisms play an important role in combating ROS
4,5
. The antioxidants 
act by raising the levels of endogenous defenses by up-regulating the expression of genes encoding 
the enzymes such as catalase (CAT), peroxidase or superoxide dismutase (SOD)
4,6
. Carbon 
tetrachloride (CCl4) is a well-known hepatotoxin and exposure to this chemical is known to induce 
oxidative stress and causes liver injury by the formation of free radicals
7
. Damage to the liver cell 
membrane leads to the leakage of the cytosolic enzymes into the blood stream
8
. The elevation of 
these cytosolic enzymes in the blood stream is a needful quantitative marker of the extent of 
hepatic damage. Furthermore, in spite of the advances in conventional medicine in the last 
decades, professionals and the lay public of developed countries pay increasing attention to 
phytomedicine
9,10
. About 600 commercial herbal formulations with claimed hepatoprotective 
activity are being sold all over the world. Around 170 phytoconstituents isolated from 110 plants 
belonging to 55 families have been reported to possess hepatoprotective activity. In India more 
than 93 medicinal plants are used in different combinations in the preparations of 40 patented 
herbal formulations
11
. However, only a small proportion of hepatoprotective plants as well as 
formulations used in traditional medicine are pharmacologically evaluated for their safety and 
efficacy
12
. The genus Schefflera is an epiphyte in the family Araliaceae. Schefflera venulosa (W. & 
A.) Harms. commonly called Schefflera vine is a large climbing shrub, with digitate compound 
leaves. The phytoconstituents are mainly caffeoyl acids, quercetin glycoside and oleanolic acid 
glycoside which helps in blood circulation and prevents cardiac and cerebral vascular diseases
13
. 
Schefflera wallichiana (W. & A.) Harms. is also an epiphyte with digitately compound leaves. 
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Phytochemical and in vitro antioxidant studies on S. venulosa and S. wallichiana have revealed 
positive results for the presence of phytochemicals such as saponins, tannins, flavonoids, alkaloids 
and reducing sugars with high antioxidant activity in aqueous extracts
14
. Hence, the present study 
has been undertaken with an aim to determine the protective effect of feeding the aqueous extract 
of S. venulosa and S. wallichiana to albino rats of the Wistar strain against the toxic effects of 
CCl4. The level of various ROS-combating enzymes in the liver, namely, catalase, peroxidase and 
superoxide dismutase and also serum enzymes namely SGOT, SGPT, ALP, total protein and total 
bilirubin were estimated in liver homogenates to assess the protection provided by the aqueous 
extracts of S. venulosa and S. wallichiana against CCl4 toxicity.  
MATERIALS AND METHOD 
Plant materials and preparation of aqueous extracts 
The leaves of S. venulosa and S. wallichiana were collected from the forests of Kodagu in Western 
Ghats (N12°20′14.97″and E75°48′24.86″). The leaves were washed thoroughly in tap water, shade 
dried and powdered. The powder (1000 g) was soaked in (1×10) ml of luke warm distilled water 
and was allowed to macerate for 48 hours at room temperature with constant stirring. The extract 
was filtered and the residue was pressed out through clean linen and added to the filtrate. The 
filtrate was evaporated to dryness in a shaker water bath at 42ºC. The yield was found to be 20.0 g. 
It was reconstituted in 0.25% olive oil, to desired concentrations and used for experiments.  
Chemicals 
Nitro blue tetrazolium (NBT) was purchased from Sisco Research Laboratories Pvt. Ltd. Mumbai, 
India. CCl4 was purchased from Qualigens Fine Chemicals, Mumbai, India. Curcumin was 
obtained from Sigma Aldrich Chemicals, Bangalore, India. All the other chemicals used were of 
analytical grade.   
Animals 
Wistar albino rats of both sexes weighing 110-190 g maintained in the Animal house of 
Department of studies in Zoology, Manasagangotri, Mysore were procured and used for the animal 
study with the CPCSEA Reg. No. 122/1999/CPCSEA, order no: UOM/IAEC/06/2013). Rats were 
bred normally and housed in separate polypropylene cages. Standard rat pellet diet was provided 
along with water ad libitum. The rats were maintained at temperature of 25±2ºC, a relative 
humidity of 50-55% and maintained under normal day/night schedule (12L: 12D).  
Experimental design 
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Animals were randomly divided into nine groups of six animals each, and treated as mentioned 
below. The CCl4 (1 ml/kg P.O.) diluted with olive oil (1:1) was administered on the 15
th
 day. 
During the experiment, all the animals were fed with normal diet and water ad libitum for 15 days. 
Group 1: Served as normal, healthy group and received olive oil (1ml/kg, P.O). 
Group 2: Served as toxic control group and received olive oil (1ml/kg, P.O). 1:1 (v/v) mixture of 
CCl4 in olive oil at a dose of 1 ml/kg, P.O. was administered on the 15
th
 day. 
Group 3: Served as extract control (for plant 1: S. venulosa) and was treated with aqueous leaf 
extract of S. venulosa (500 mg/kg, P.O.). 
Group 4: Served as extract control (for plant 2: S. wallichiana) and was treated with aqueous leaf 
extract of S. wallichiana (500 mg/kg, P.O.). 
Group 5: Treated with the aqueous leaf extract of S. venulosa (250 mg/kg, P.O). 1:1 (v/v) mixture 
of CCl4 in olive oil at a dose of 1 ml/kg, P.O. was administered on the 15
th
 day. 
Group 6: Treated with aqueous leaf extract of S. wallichiana (250 mg/kg, P.O.). 1:1 (v/v) mixture 
of CCl4 in olive oil at a dose of 1 ml/kg, P.O. was administered on the 15
th
 day. 
Group 7: Treated with the aqueous leaf extract of S. venulosa (500 mg/kg, P.O.). 1:1 (v/v) mixture 
of CCl4 in olive oil at a dose of 1 ml/kg, P.O. was administered on the 15
th
 day. 
Group 8: Treated with the aqueous leaf extract of S. wallichiana (500 mg/kg, P.O.). 1:1 (v/v) 
mixture of CCl4 in olive oil at a dose of 1 ml/kg, P.O. was administered on the 15
th
 day. 
Group 9: Served as standard group and received Curcumin (5 mg/kg). 1:1 (v/v) mixture of CCl4 in 
olive oil at a dose of 1 ml/kg, P.O. was administered on the 15
th
 day. 
Biochemical Parameters 
The animals were monitored for change in body weight and food consumption during the 
experiment. At the end of the experiment, all the animals were necropsied by mild Diethylether 
anesthesia and were sacrificed by cardiac puncture. Blood samples were collected from each group 
and the serum was separated at 2500 RPM for 15 min and biochemical investigations used for the 
assay of marker enzymes such as SGPT, SGOT, ALP, serum bilirubin and total protein were 
carried out using standard kits procured from Span Diagnostics
® 
(Surat, India). Livers were 
dissected out and a portion was immediately preserved in 10% (v/v) formaldehyde solution for 
histopathological study. The remaining liver tissue was homogenized in ice cold buffer, 
centrifuged and utilized to examine the antioxidant status. Catalase (CAT) was tested 
spectrophotometrically by measuring the rate of decomposition of hydrogen peroxide at 240 nm as 
described by Aebi
15
. The peroxidase (Px) was tested by the method of Reddy et al.
16
, the tissue 
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superoxide dismutase (SOD) was measured by the Nitro blue tetrazolium (NBT) decrease method 
of Kakkar et al.
17
 
Histopathological studies 
Histopathological studies of the livers of the different groups of rats were carried out to determine 
the effect of protection offered by feeding the aqueous leaf extracts of S. venulosa and S. 
wallichiana against the toxic effects of CCl4. 
Statistical analysis 
All values were expressed as Mean± Standard Error of the Mean (SEM). Statistical analysis was 
done using Statistical Analysis System (SAS) (16.0 version). The biochemical parameters were 
analyzed statistically using one-way analysis of variance (ANOVA), followed by a Duncan’s 
multiple range test. The P value of <0.05 was considered as statistically significant. 
RESULTS AND DISCUSSION  
Effect of AESV and AESW on serum hepatic enzyme levels 
In the 15 days of hepatotoxicity study, there was no death record, nor signs of changes in the rats 
in any treated groups. The effects of aqueous leaf extracts of S. venulosa and S. wallichiana on 
serum glutamate oxalate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), 
alkaline phosphatase (ALP), total protein (TP) and total bilirubin (TB) levels and change in weight 
of the liver in CCl4 induced liver damage in rats are summarized in Table 1. Administration of 
CCl4 (1 ml/kg p.o) on the 15
th
 day resulted a significant (P<0.05) elevation of hepatospecific serum 
marker enzymes SGOT, SGPT, ALP, total protein and total bilirubin in CCl4 treated groups in 
comparison with the normal group. Administration of aqueous leaf extracts of S. venulosa and S. 
wallichiana (Group 7 and Group 8, Table 1) and Curcumin at the dose of 5 mg/kg (Group 9, Table 
1), the level of these enzymes were found retrieving towards normalcy. With CCl4 treatment, the 
mean liver weight increased to 4.87±0.18 g/100g b.w. from that of normal controls 
2.66±0.10g/100g b.w., which was found to be statistically significant. The low dose pretreatment 
(250 mg/kg, P.O.) with aqueous extract of both the plants also resulted in an increase in the mean 
liver weight as compared to normal, which was statistically significant in Group 5 and 6 (Table 1). 
However, pretreatment with high dose (500 mg/kg, P.O.) showed the mean liver weight to return 
to near normalcy. Our results indicate the elevation of serum marker enzymes concentration 
SGOT, SGPT and ALP beside histological study. CCl4 as many halogenated alkanes has been 
widely used in our daily life, but has been banned or restricted because of their distinct toxicity. Its 
production has steeply declined since 1980’s; it was proved to be one of the most powerful 
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hepatotoxins capable of forming trichlomethyl and trichloromethylperoxyl radicals
18
. Yet CCl4 
continues to provide an important service in scientific research as a model substance to 
demonstrate the mechanisms of action of hepatotoxic effects and carcinogenicity or to evaluate 
hepatoprotective agents
19
. In living systems, the liver is considered to be highly sensitive to toxic 
agents. Schefflera, gains its importance in the present work because of its potent antioxidant 
activity. The present study is the first report on hepatotoxicity studies of Schefflera species. The 
most important member of the same family, commonly called Panax ginseng is one of the most 
valuable medicinal plants of the Araliaceae particularly used in Korea, China and Japan
20
. Ginseng 
and its principal components, ginsenosides, have shown a wide array of pharmacological activities 
including beneficial role in the regulation of liver functions and the treatment of liver disorders of 
acute/chronic hepatotoxicity, hepatitis, hepatic fibrosis/ cirrhosis, liver hepatectomy, liver 
transplantation and even liver failure and HCC
21
. To diagnose hepatotoxicity, serum enzymes 
SGOT, SGPT and ALP are the most sensitive markers employed
22
. SGOT is normally found in 
different tissues as liver, kidney, heart, muscle and brain. It enters into systemic circulation when 
any one of these tissues is damaged. The rise in the SGOT is usually accompanied by an elevation 
in the levels of SGPT, which play a vital role in the conversion of amino acids to keto acids
23
. 
SGPT is most concentrated in the liver. It leaks out into the bloodstream as the result of liver 
injury. Therefore, it is considered as a specific indicator of liver status
24
. Alkaline phosphatase is 
the key enzyme used test to detect obstruction in the biliary system. It is found both in the liver and 
the bile and it leaks into the blood stream in a manner similar to that of the SGOT and SGPT
25
. It 
is also found in other organs such as bone, placenta and intestine. The intoxication by CCl4 and its 
metabolites (CCl3 radical) causes acute hepatic failure. This radical, which is formed by a 
metabolic enzyme (Cytochrome P450), induce peroxidation of the unsaturated fatty acids of cell 
membrane and leads to membrane injury and leakage of sensitive markers of hepatocellular injury, 
such as serum SGOT and SGPT
26
. In the present study, it was observed that the animals treated 
with CCl4 resulted in significant hepatic damage as shown by the elevated levels of serum markers. 
These changes in the marker levels will reflect in hepatic structural integrity. The pretreatment 
with AESV and AESW, at the dose of 500 mg/kg, significantly attenuated the elevated levels of 
serum markers. The normalization of serum markers by AESV and AESW suggests that they are 
able to condition hepatocytes so as to protect the membrane integrity against CCl4 induced leakage 
of marker enzymes into the circulation. This elevation results from damage to mitochondrial, cell 
membrane damage in hepatocytes and the liver biliary obstruction (cholestasis) respectively
27
. The 
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above changes can be considered as an expression of the functional improvement of hepatocytes, 
which may be caused by an accelerated regeneration of parenchyma cells.  
Table 1: Effect of aqueous leaf extract of S. venulosa (AESV) and S. wallichiana (AESW) on 
liver marker enzymes in the serum of experimental groups. 
Groups SGOT 
U/L 
SGPT 
U/L 
ALP 
U/L 
TB 
mg/dl 
TP 
gm/dl 
Liver Weight 
(g/100g body 
weight) 
Group I 
(Normal healthy group) 
80.3±2.9
a 
 
49.0±2.1
a
 92.6±3.1
a
 0.58±0.02
a
 7.8±0.23
e 
2.66±0.10
a
 
Group II 
(Toxic control group) 
201.1±5.5
f 
 
185.0±2.6
e 
214.8±4.6
e 
2.04±0.04
f 
3.86±0.65
a
 4.87±0.18
e 
Group III 
(Extract control for S. 
venulosa) 
82.0±1.8
a 
 
51.0±2.4
ab 
89.1±2.3
a
 0.59±0.02
ab 
7.75±0.21
e 
2.92±0.27
ab 
Group IV 
(Extract control for S. 
wallichiana) 
84.1±3.7
a
 
 
48.5±2.6
a
 91.5±2.6
a 
0.69±0.02
ab 
7.33±0.18
de 
3.03±0.20
ab 
Group V 
(Treated with AESV 250 
mg/kg) 
176.1±3.7
d 
 
107.8±3.2
d
 159.5±3.8
c 
1.13±0.03
d
 5.60±0.23
bc 
3.84±0.21
cd 
Group VI 
(Treated with AESW 250 
mg/kg) 
188.0±3.2
e 
 
116.8±4.5
d
 176.0±3.1
d
 1.77±0.04
e 
4.28±0.17
a
 4.01±0.16
d
 
Group VII 
(Treated with AESV 500 
mg/kg) 
96.3±2.7
b 
 
68.1±3.7
c 
97.0±3.4
a
 0.99±0.05
c 
6.20±0.25
c 
2.96±0.24
ab 
Group VIII 
(Treated with AESW 500 
mg/kg) 
120.3±4.8
c 
 
70.3±3.6
c 
113.0±5.0
b 
1.06±0.04
cd 
5.13±0.20
b 
3.31±0.15
bc 
Group IX 
(Standard group) 
90.6±2.8
ab 
 
58.6±2.9
b 
94.0±2.6
a
 0.70±0.02
b 
7.05±0.26
 d
 2.68±0.10
a
 
All values are mean of three replicates and are expressed as mean± SEM (n=06 in each group). 
Numbers in the same column followed by the same letter are not significantly different at P<0.05. 
U/L = Units per liter; mg/dl = milligram per deciliter; g/dl = gram per deciliter 
Effect of AESV and AESW on antioxidant enzymes of liver tissue 
The effects of AESV and AESW on the enzymatic antioxidants, namely superoxide dismutase 
(SOD), catalase (CAT) and peroxidase (Px) are shown in Table 2. Administration of AESV and 
AESW (Group 7 and 8, Table 2) increased the activities of SOD, CAT and Px in CCl4 induced 
liver damage in rats to prevent the accumulation of excessive free radicals and protect the liver 
from CCl4 intoxication. A significant decrease in the activities of enzymatic antioxidants (SOD, 
CAT, Px) were noted after single administration of CCl4 (Group 2, Table 2). Upon administration 
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of AESV and AESW (Group 7 and 8, Table 2) the enzymatic antioxidants were significantly 
(P<0.05) reversed to near normal. The effects of AESV and AESW were comparable with that of 
standard reference drug Curcumin. The body has an effective mechanism to prevent and neutralize 
the free radical induced damage. This is accomplished by a set of endogenous antioxidant enzymes 
such as SOD, CAT, Px, etc, which are important scavengers of superoxide ion and hydrogen 
peroxide. These enzymes prevent the generation of hydroxyl radical and protect the cellular 
constituents from the oxidative damage. It is known that SOD converts superoxide anion into H2O2 
and O2, whereas CAT reduces H2O2 to H2O, resulting in the detoxification of free radicals
28, 29
. 
Therefore the reduction in the activity of these enzymes may result in a number of deleterious 
effects due to accumulation of superoxide radicals and hydrogen peroxide. In the present study, it 
was observed that the AESV and AESW significantly increased the hepatic SOD activity in CCl4 -
induced liver damage in rats.  AESV and AESW have reduced the reactive free radicals that might 
lessen oxidative damage to the tissue and improve the activities of the hepatic antioxidant 
enzymes. Hence it may be opined that the mechanism of hepatoprotection by AESV and AESW is 
due to its antioxidant effect. 
Table 2: Effect of aqueous leaf extracts of S. venulosa (AESV) and S. wallichiana (AESW) on 
liver antioxidant enzymes in the serum of experimental groups. 
Groups SOD 
(U/min/mg protein) 
CAT 
(U/min/mg protein) 
Px 
(U/min/mg protein) 
Group I 
(Normal healthy group) 
48.43±0.73
a 
 
26.51±0.90
a 
0.99±0.03
a 
Group II 
(Toxic control group) 
18.96±0.98
h 
 
8.78±0.56
f 
0.27±0.01
f 
Group III 
(Extract control for S. venulosa) 
46.01±0.50
b 
 
26.33±0.83
a 
 
0.79±0.02
c 
Group IV 
(Extract control for S. wallichiana) 
45.08±0.33
b 
 
25.18±0.88
a 
0.68±0.02
d 
Group V 
(Treated with AESV 250 mg/kg) 
28.44±0.47
f 
 
14.40±0.76
de 
0.49±0.03
e 
Group VI 
(Treated with AESW 250 mg/kg) 
23.54±0.64
g 
 
13.17±0.87
e 
0.44±0.02
e 
Group VII 
(Treated with AESV 500 mg/kg) 
35.75±0.34
d 
 
19.30±0.54
c 
0.68±0.02
d 
Group VIII 
(Treated with AESW 500 mg/kg) 
31.98±0.63
e 
 
16.05±0.41
d 
0.64±0.03
d 
Group IX 
(Standard group) 
42.45±0.67
c 
 
21.94±0.80
b 
0.90±0.02
b  
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All values are mean of three replicates and are expressed as mean± SEM (n=06 in each group). 
Different letters within in a column indicate significant differences by Duncan’s multiple range 
tests at P<0.05. 
Histopathological studies 
Histopathological studies of rat liver tissue from Group 1 animals show predominantly normal 
hepatic architecture with normal lobules and hepatocytes (Figure. 1A). In CCl4-treated group 
(Figure. 1B), severe hepatotoxicity was observed by distorted hepatic lobular architecture with foci 
of necrotic hepatocytes and foci of mixed inflammatory exudates. Normal hepatic architecture with 
normal lobules and hepatocytes were observed in Figure. 1C and D. Severe necrosis and damage to 
hepatic cells was observed in sections E, F and H (Figure. 1). Minimal distortion of hepatic lobules 
with normal cells was observed in animals (Figure. 1G). The liver taken from animals treated with 
the standard drug Curcumin showed the mildly distorted and regenerating lobules (Figure. 1I).  
 
Figure 1: Histopatological sections of the liver 
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In the CCl4-induced liver damage, the free radicals are generated in which the cytotoxic effect is 
not localized but can be propagated intercellularly, thereby increasing the interaction of these 
radicals with phospholipids structures and inducing peroxidation process that destroy the organ 
structure. Our studies indicated that in the case of control, the hepatocytes having a normal hepatic 
architecture were visible. However, in case of the CCl4-treated rats, total loss of hepatic 
architecture and areas of hemorrhage and necrosis were seen. In case of the rats pretreated with the 
aqueous leaf extracts of S. venulosa and S. wallichiana [500 mg/kg, b.w.], followed by exposure to 
CCl4, the liver showed to retain the normal hepatic architecture with few areas of hemorrhage 
between the columns of hepatocytes. 
Normal healthy rats, showing normal hepatic cells with normal lobules (A). Distorted hepatic 
lobular architecture with foci of necrotic hepatocytes in CCl4 treated rats (B). Normal hepatic 
architecture with normal lobules and hepatocytes in extract control groups (C and D). Liver 
sections of animals treated with 250 mg extract and CCl4 showing distorted hepatic lobules, 
extensive chronic inflammatory foci with dilated central veins and stasis of blood (E, F and H). 
Animals treated with 500 mg of the extract and CCl4 showing minimal distortion of hepatic lobules 
(G). Animals treated with standard drug Curcumin showing mildly distorted hepatic lobular 
architecture (I). 
CONCLUSION 
The data presented in our study suggest that the aqueous leaf extract of S. venulosa has potent 
antioxidant activity against free radicals, thus preventing oxidative damage to major biomolecules 
and afford significant protection against CCl4 - induced oxidative stress and liver damage in rats 
when compared to the aqueous leaf extract of S. wallichiana.  Further studies on the isolation and 
characterization of compounds responsible for the hepatoprotective activity are needed to be 
evaluated for their potential benefits.  
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